S&P 500   3,351.60 (+1.61%)
DOW   27,584.06 (+1.51%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
S&P 500   3,351.60 (+1.61%)
DOW   27,584.06 (+1.51%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
S&P 500   3,351.60 (+1.61%)
DOW   27,584.06 (+1.51%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
S&P 500   3,351.60 (+1.61%)
DOW   27,584.06 (+1.51%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
Log in
ASX:PCK

Painchek Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
PainChek Ltd. provides pain assessment solutions primarily in Australia and Europe. The company offers PainChek, a smartphone and tablets pain assessment and monitoring device that automatically detects pain through facial recognition technology. It serves pre-verbal children and patients suffering with dementia. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Ltd. in January 2018. PainChek Ltd. is based in Sydney, Australia.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.00 out of 5 stars


Industry, Sector and Symbol

Stock Exchange ASX
Industry Health Information Services
Sub-IndustryN/A
SectorMedical
Current SymbolASX:PCK
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.painchek.com
Phone1800 098 809

Debt

Debt-to-Equity RatioN/A
Current Ratio2.97
Quick Ratio2.97

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$297,175.00
Price / Sales0.00
Cash FlowN/A
Price / Cash FlowN/A
Book ValueA$0.00 per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive PCK News and Ratings via Email

Sign-up to receive the latest news and ratings for PCK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Painchek (ASX:PCK) Frequently Asked Questions

Who are some of Painchek's key competitors?

Some companies that are related to Painchek include 1ST Group (1ST), Alcidion Group (ALC), CannaOne Technologies (CNNA), CannaOne Technologies (CNONF), CloudMD Software & Services (DOC), CloudMD Software & Services (DOCRF), CogState (CGS), CompuMed (CMPD), Corum Group (COO), Emerald Clinics (EMD), eWELLNESS HEALTHCARE (EWLL), Global Health (GLH), ICSGlobal (ICS), Jayex Healthcare (JHL) and Mach7 Technologies (M7T).
View all competitors.

Who are Painchek's key executives?

Painchek's management team includes the following people:
  • Mr. Philip Daffas BSc, Dip EENG, MBA, GAICD, MD. CEO & Director
  • Mr. Ian Hobson A.C.I.S., F.C.A., M.A.I.C.D., B.BUS, FCA, ACSA, MA, CFO & Company Sec. (Age 55, Pay $122.83k)
  • Mr. Scott Robertson, Chief Technology Officer
  • Prof. Jeff Hughes, Chief Scientific Officer
  • Mr. David Allsopp, Head of Bus. Devel. ANZ

What is Painchek's stock symbol?

Painchek trades on the ASX under the ticker symbol "PCK."

How big of a company is Painchek?

Painchek has a market capitalization of $0.00 and generates $297,175.00 in revenue each year.

What is Painchek's official website?

The official website for Painchek is www.painchek.com.

How can I contact Painchek?

The company can be reached via phone at 1800 098 809.

This page was last updated on 9/28/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.